AngioDynamics | ANGO - Operating Expenses


AngioDynamics reported $81.98M in Operating Expenses for its fiscal quarter ending in February of 2025.





Operating Expenses Change Date
AngioDynamics USD 81.98M 1.96M Feb/2025
AtriCure USD 134.06M 8.27M Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
ICU Medical USD 510.13M 11.93M Sep/2025
Inogen USD 49.14M 665K Sep/2024
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.26B 283M Sep/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 10.89M 209.57M Sep/2024
Smiths GBP 1.37B 80M Dec/2025
Surmodics USD -245.35M 363.49M Sep/2024
Tandem Diabetes Care USD 272.12M 421K Sep/2025
Teleflex USD 3.82B 3.22B Sep/2025
Terumo JPY 229.87B 25.79B Sep/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025